Trial Profile
A Phase 1 Safety Study of Enzastaurin plus Bortezomib Therapy in the Treatment of Relapsed or Refractory Multiple Myeloma
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2007
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Enzastaurin (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 25 Jul 2007 New trial record.